0001415889-24-006070.txt : 20240301
0001415889-24-006070.hdr.sgml : 20240301
20240301160524
ACCESSION NUMBER: 0001415889-24-006070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Busse Falko
CENTRAL INDEX KEY: 0001739999
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 24709572
MAIL ADDRESS:
STREET 1: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
4
1
form4-03012024_040301.xml
X0508
4
2024-02-28
0001109354
BRUKER CORP
BRKR
0001739999
Busse Falko
40 MANNING ROAD
BILLERICA
MA
01821
false
true
false
false
PRESIDENT, BIOSPIN GROUP
0
Common Stock
2024-02-28
4
M
0
12000
19.82
A
44859
D
Common Stock
2024-02-28
4
M
0
7097
22.19
A
51956
D
Common Stock
2024-02-28
4
M
0
4384
34.02
A
56340
D
Common Stock
2024-02-28
4
M
0
4641
41.95
A
60981
D
Common Stock
2024-02-28
4
S
0
13852
86.06
D
47129
D
Common Stock
2024-02-28
4
S
0
12770
84.97
D
34359
D
Common Stock
2024-02-28
4
S
0
1500
84.48
D
32859
D
Stock Option (Right to Purchase)
19.82
2024-02-28
4
M
0
12000
0
D
2025-08-07
Common Stock
12000
0
D
Stock Option (Right to Purchase)
22.19
2024-02-28
4
M
0
7097
0
D
2026-10-04
Common Stock
7097
0
D
Stock Option (Right to Purchase)
34.02
2024-02-28
4
M
0
4384
0
D
2028-08-09
Common Stock
4384
0
D
Stock Option (Right to Purchase)
41.95
2024-02-28
4
M
0
4641
0
D
2029-08-08
Common Stock
4641
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.52 to $86.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.52 to $85.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.46 to $84.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
/s/ Michael A Simone, Attorney-in-Fact
2024-03-01